Home › Kanser ng Hipoparynk
Pag-aaral pangklinika para sa Kanser ng Hipoparynk na nagre-recruit sa U.S.
19 pag-aaral para sa Kanser ng Hipoparynk ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Atlanta, GA6 pag-aaral
- Chicago, IL6 pag-aaral
- Stevens Point, WI5 pag-aaral
- Joliet, IL5 pag-aaral
- Peoria, IL5 pag-aaral
- Bloomington, IL5 pag-aaral
- Wausau, WI5 pag-aaral
- Richmond, VA5 pag-aaral
- Cape Girardeau, MO5 pag-aaral
- Milwaukee, WI5 pag-aaral
- Kansas City, MO5 pag-aaral
- New York City, NY4 pag-aaral
- Edison, NJ4 pag-aaral
- Queens, NY4 pag-aaral
- Waukegan, IL4 pag-aaral
- Green Bay, WI4 pag-aaral
- Cedar Rapids, IA4 pag-aaral
- Evanston, IL4 pag-aaral
- Danville, IL4 pag-aaral
- Fargo, ND4 pag-aaral
- Lansing, MI4 pag-aaral
- Omaha, NE4 pag-aaral
- Champaign, IL4 pag-aaral
- Decatur, IL4 pag-aaral
- Aurora, IL4 pag-aaral
- St. Louis, MO4 pag-aaral
- Galesburg, IL4 pag-aaral
- Naperville, IL4 pag-aaral
- Flint, MI4 pag-aaral
- Oklahoma City, OK4 pag-aaral
- Charleston, IL4 pag-aaral
- Cicero, IL4 pag-aaral
- North Peoria, IL4 pag-aaral
- Waterford, MI4 pag-aaral
- Bozeman, MT4 pag-aaral
- Duluth, MN4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- Baltimore, MD4 pag-aaral
- Cincinnati, OH4 pag-aaral
- Louisville, KY4 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- Arkansas4 pag-aaral
- California7 pag-aaral
- Colorado6 pag-aaral
- Florida8 pag-aaral
- Georgia6 pag-aaral
- Idaho3 pag-aaral
- Illinois7 pag-aaral
- Indiana4 pag-aaral
- Iowa6 pag-aaral
- Kansas6 pag-aaral
- Kentucky4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts5 pag-aaral
- Michigan5 pag-aaral
- Minnesota6 pag-aaral
- Missouri6 pag-aaral
- Montana4 pag-aaral
- Nebraska4 pag-aaral
- New Jersey4 pag-aaral
- New York8 pag-aaral
- North Carolina5 pag-aaral
- North Dakota4 pag-aaral
- Ohio8 pag-aaral
- Oklahoma4 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania6 pag-aaral
- South Dakota3 pag-aaral
- Texas3 pag-aaral
- Virginia5 pag-aaral
- Wisconsin6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06997068BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07441681Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT01473784Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2025 · NCT00900419Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.